Diagnostics & Research Stocks
| # | Last 7 Days | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1435 | BLLN BillionToOne, Inc. - Class A common stock | 95.03 USD | -0.25% | +1.97% | -26.63% | -4.97% | 4.48 B USD | ||
| 1604 | GRAL GRAIL, Inc. - Common Stock | 79.54 USD | +2.01% | +18.13% | +15.16% | -19.66% | 3.55 B USD | ||
| 1834 | NEOG Neogen Corporation - Common Stock | 11.95 USD | +1.01% | +4.00% | +25.13% | +111.88% | 2.61 B USD | ||
| 1859 | CDNA CareDx, Inc. - Common Stock | 48.61 USD | +3.45% | +7.24% | +30.64% | +226.02% | 2.51 B USD | ||
| 1957 | NEO NeoGenomics, Inc. - Common Stock | 16.98 USD | +2.72% | +8.02% | +21.29% | +160.83% | 2.18 B USD | ||
| 2031 | PSNL Personalis, Inc. - Common Stock | 18.38 USD | +8.89% | +32.23% | +53.81% | +272.82% | 1.96 B USD | ||
| 2402 | OPK Opko Health, Inc. - Common Stock | 1.48 USD | +1.37% | +9.63% | +20.33% | +4.96% | 1.10 B USD | ||
| 2433 | CSTL Castle Biosciences, Inc. - Common stock | 34.20 USD | +3.86% | +15.93% | +36.25% | +38.97% | 1.04 B USD | ||
| 2502 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 6.41 USD | +1.26% | +12.06% | +21.17% | +256.11% | 943.54 M USD | ||
| 2871 | FLGT Fulgent Genetics, Inc. - Common Stock | 19.90 USD | -0.10% | +8.15% | -0.25% | -15.79% | 547.55 M USD | ||
| 3223 | PRE Prenetics Global Limited - Class A Ordinary Share | 20.20 USD | +12.41% | +2.75% | -2.37% | +181.34% | 340.86 M USD | ||
| 3323 | MYGN Myriad Genetics, Inc. - Common Stock | 3.20 USD | -0.62% | +6.31% | -43.86% | -61.31% | 306.08 M USD | ||
| 3393 | BDSX Biodesix, Inc. - Common Stock | 26.63 USD | +10.82% | +11.52% | +20.33% | +112.87% | 280.98 M USD | ||
| 3443 | LAB Standard BioTools Inc. - Common Stock | 0.67 USD | +3.08% | -4.29% | -21.18% | -46.83% | 263.03 M USD | ||
| 3549 | STIM Neuronetics, Inc. - Common Stock | 3.00 USD | -2.91% | -8.26% | +68.54% | -11.24% | 228.59 M USD | ||
| 3647 | XGN Exagen Inc. - Common Stock | 7.92 USD | +1.80% | +19.64% | +67.09% | -21.58% | 191.86 M USD | ||
| 3795 | IMDX Insight Molecular Diagnostics Inc. - Common Stock | 4.34 USD | +0.93% | +1.17% | -10.88% | +67.57% | 142.02 M USD | ||
| 3923 | BNR Burning Rock Biotech Limited - American Depositary Shares | 9.70 USD | -10.93% | +5.66% | +3.85% | -67.58% | 104.96 M USD | ||
| 4106 | DRIO DarioHealth Corp. - Common Stock | 7.49 USD | +4.46% | -1.58% | +0.13% | -32.95% | 73.40 M USD | ||
| 4233 | PRPO Precipio, Inc. - Common Stock | 30.45 USD | +3.47% | +32.05% | +28.16% | +45.07% | 54.51 M USD |
News Diagnostics & Research Stocks
Invesco Discovery Mid Cap Growth Fund Q2 2026 Portfolio Performance
Stock Market Week Ahead: A Choppy Market Heads For Nvidia Earnings, Jackson Hole
Illumina, Inc. Post Earnings: Buy On A Pullback (NASDAQ:ILMN)
Palantir, Freeport Clear Buy Points, Lead Five Stocks To Watch
Prenetics Global Limited (PRE) Q2 2026 Earnings Call Transcript
Duquesne Management Opens New Position in Alphabet Stock as Google Posts Blowout Q2 Results
Mettler-Toledo (MTD) Upgraded to Buy: Here's Why
Gainers Diagnostics & Research Stocks
PRE Prenetics Global Limited - Class A Ordinary Share | 20.20 | +12.41% |
XWEL XWELL, Inc. - Common Stock | 1.04 | +11.83% |
BIAFW bioAffinity Technologies, Inc. - Warrant | 0.1165 | +11.70% |
BDSX Biodesix, Inc. - Common Stock | 26.63 | +10.82% |
PSNL Personalis, Inc. - Common Stock | 18.38 | +8.89% |
TWST Twist Bioscience Corporation - Common Stock | 145.59 | +6.79% |
DRIO DarioHealth Corp. - Common Stock | 7.49 | +4.46% |
CSTL Castle Biosciences, Inc. - Common stock | 34.20 | +3.86% |
Losers Diagnostics & Research Stocks
ISPC iSpecimen Inc. - Common Stock | 1.69 | -25.55% |
BNR Burning Rock Biotech Limited - American Depositary Shares | 9.70 | -10.93% |
VNRX VolitionRX Limited Common Stock | 0.41 | -6.82% |
STIM Neuronetics, Inc. - Common Stock | 3.00 | -2.91% |
NDRA ENDRA Life Sciences Inc. - Common Stock | 4.49 | -2.18% |
QGEN Qiagen N.V. Common Shares | 44.10 | -1.80% |
ICLR ICON plc - Ordinary Shares | 172.23 | -1.17% |
MYGN Myriad Genetics, Inc. - Common Stock | 3.20 | -0.62% |